loadpatents
Patent applications and USPTO patent grants for Frye; Christopher Carl.The latest application filed is for "recombinantly engineered, lipase/esterase-deficient mammalian cell lines".
Patent | Date |
---|---|
Anti-coronavirus antibodies and methods of use Grant 11,447,541 - Westendorf , et al. September 20, 2 | 2022-09-20 |
Recombinantly Engineered, Lipase/esterase-deficient Mammalian Cell Lines App 20220251172 - FRYE; Christopher Carl ;   et al. | 2022-08-11 |
Anti-coronavirus antibodies and methods of use Grant 11,370,828 - Westendorf , et al. June 28, 2 | 2022-06-28 |
Anti-Coronavirus Antibodies and Methods of Use App 20210388066 - WESTENDORF; Kathryn ;   et al. | 2021-12-16 |
Anti-Coronavirus Antibodies and Methods of Use App 20210292393 - WESTENDORF; Kathryn ;   et al. | 2021-09-23 |
Anti-CD137 antibodies Grant 10,906,983 - Frye , et al. February 2, 2 | 2021-02-02 |
Anti-cd137 Antibodies App 20200377607 - FRYE; Christopher Carl ;   et al. | 2020-12-03 |
Anti-cd137 Antibodies App 20200157234 - FRYE; Christopher Carl ;   et al. | 2020-05-21 |
Muteins of fibroblast growth factor 21 Grant 7,655,627 - Frye , et al. February 2, 2 | 2010-02-02 |
Muteins of fibroblast growth factor 21 Grant 7,622,445 - Frye , et al. November 24, 2 | 2009-11-24 |
Muteins of fibroblast growth factor 21 Grant 7,582,607 - Frye , et al. September 1, 2 | 2009-09-01 |
Muteins Of Fibroblast Growth Factor 21 App 20090118190 - Beals; John Michael ;   et al. | 2009-05-07 |
Muteins of fibroblast growth factor 21 Grant 7,491,697 - Beals , et al. February 17, 2 | 2009-02-17 |
Muteins of Fibroblast Growth Factor 21 App 20080103096 - Frye; Christopher Carl ;   et al. | 2008-05-01 |
Muteins OF Fibroblast Growth Factor 21 App 20070299007 - Frye; Christopher Carl ;   et al. | 2007-12-27 |
Muteins of Fibroblast Growth Factor 21 App 20070293430 - Frye; Christopher Carl ;   et al. | 2007-12-20 |
Muteins of fibroblast growth factor 21 App 20070142278 - Beals; John Michael ;   et al. | 2007-06-21 |
Recombinant bovine thrombin App 20060205041 - Frye; Christopher Carl ;   et al. | 2006-09-14 |
Expression system App 20050009029 - Frye, Christopher Carl ;   et al. | 2005-01-13 |
Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations Grant 6,136,565 - Best , et al. October 24, 2 | 2000-10-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.